Energy Transfer's Earnings Soar on Record Volumes. Is the High-Yielding Pipeline Stock Still a Buy?

Energy Transfer reported first-quarter adjusted EBITDA of over $4.9 billion, up 20% year over year, and distributable cash flow of $2.7 billion, up 17%. It raised full-year EBITDA guidance to $18.2 billion-$18.6 billion from $17.45 billion-$17.85 billion and increased growth capex plans to $5.5 billion-$5.9 billion, supported by record volumes and strong export demand. The company also reaffirmed a 3%-5% annual distribution growth target, reinforcing the positive earnings and cash-flow outlook.

Analysis

ET’s print matters less for the headline growth rate than for what it says about the durability of U.S. midstream pricing power: utilization is now tight enough that incremental throughput is flowing through with unusually high operating leverage. The bigger second-order effect is on capital allocation across the midstream complex—management teams with visible backlogs can now justify higher growth capex while still preserving distribution coverage, which should support a bid for assets with fee-based exposure and long-dated in-service visibility.

The market is likely underestimating how much of this is self-reinforcing. Expansion projects at affiliated entities and completed debottlenecking create a flywheel: more volume begets more terminals/fractionation/export activity, which improves economics enough to greenlight the next wave of projects. That tends to compress the gap between “value” and “growth” MLPs over 6-18 months, especially for operators with scale and integrated logistics footprints.

The main risk is that the current uplift is partially geopolitical and therefore more duration-sensitive than the market may be pricing. If Middle East supply normalizes or shipping bottlenecks ease, near-term record volumes can plateau before the newly sanctioned projects contribute, creating a temporary growth air pocket in late 2025/2026. In that scenario, the stock can still work, but the multiple expansion case becomes more vulnerable because the current rerating already reflects a lot of the good news.

Contrarian view: consensus is focusing on distribution yield and visible backlog, but the real hidden variable is project execution and returns on incremental capex. If management keeps raising spend faster than it can de-risk returns, the market may eventually discount growth capex as a drag rather than a catalyst. For now, the setup still favors owners of scarce infrastructure, but the trade is better expressed as relative value than an outright chase after a strong YTD move.

Key Decisions for Investors

• Stay long ET on pullbacks over the next 1-3 months, but size modestly: the combination of accelerating EBITDA and visible project backlog supports another leg higher, though upside is increasingly dependent on multiple retention rather than just earnings revisions.
• Pair trade: long ET / short a higher-beta midstream name with less visible backlog or weaker coverage, to isolate relative operating leverage and reduce exposure to a sector-wide de-rating if rates or commodities wobble.
• Buy SUN as a secondary beneficiary only if you want a cheaper, lagging catch-up trade; use ET strength as a hedge because SUN’s rerating thesis is more dependent on sponsor-driven spillover and less on standalone upside.
• Consider ET Jan/Apr call spreads instead of outright stock if you expect another guidance lift within 1-2 quarters; this captures the rerating while limiting downside if geopolitics normalize and volume growth decelerates.
• If ET rallies another 10%+ without a follow-through in project approvals, trim exposure and rotate into cash-flow stable peers; the risk/reward worsens once the market fully capitalizes the current backlog narrative.